Targeting Histone Demethylases in MYC-Driven Neuroblastomas with Ciclopirox.
about
Hypoxia and Hormone-Mediated Pathways Converge at the Histone Demethylase KDM4B in Cancer.Ciclopirox activates ATR-Chk1 signaling pathway leading to Cdc25A protein degradation.Methylation of DNA and chromatin as a mechanism of oncogenesis and therapeutic target in neuroblastoma.KDM5A Regulates a Translational Program that Controls p53 Protein Expression
P2860
Targeting Histone Demethylases in MYC-Driven Neuroblastomas with Ciclopirox.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Targeting Histone Demethylases in MYC-Driven Neuroblastomas with Ciclopirox.
@en
Targeting Histone Demethylases in MYC-Driven Neuroblastomas with Ciclopirox.
@nl
type
label
Targeting Histone Demethylases in MYC-Driven Neuroblastomas with Ciclopirox.
@en
Targeting Histone Demethylases in MYC-Driven Neuroblastomas with Ciclopirox.
@nl
prefLabel
Targeting Histone Demethylases in MYC-Driven Neuroblastomas with Ciclopirox.
@en
Targeting Histone Demethylases in MYC-Driven Neuroblastomas with Ciclopirox.
@nl
P2093
P2860
P50
P1433
P1476
Targeting Histone Demethylases in MYC-Driven Neuroblastomas with Ciclopirox.
@en
P2093
Alaa M AlTahan
Amit C Nathwani
Andrew M Davidoff
Ashutosh Mishra
Brandon Young
Jesse Davidson
Jonathan Low
P2860
P304
P356
10.1158/0008-5472.CAN-16-0826
P407
P577
2017-07-06T00:00:00Z